What does AADI mean in UNCLASSIFIED

Aurolab Aqueous Drainage Implant (AADI) is a surgical device designed to manage glaucoma, a condition characterized by increased intraocular pressure that can damage the optic nerve. It is a biocompatible, self-regulating shunt that helps drain excess fluid from the eye, reducing pressure and preserving vision.

The AADI consists of a thin, flexible tube that is surgically implanted into the eye. One end of the tube is placed in the anterior chamber, the fluid-filled space in front of the iris, while the other end is anchored to the sclera, the white outer layer of the eye. The device acts as a valve, allowing excess fluid to drain from the anterior chamber and flow into the subconjunctival space, reducing intraocular pressure.

The AADI offers several advantages over traditional glaucoma treatments. It is less invasive than other surgical procedures, requiring only a small incision. It is also adjustable, allowing the surgeon to fine-tune the flow rate to achieve optimal pressure control. Additionally, the AADI has a low risk of complications, such as infection or scarring.

AADI surgery is typically recommended for patients with primary open-angle glaucoma or secondary glaucoma who have not responded to other treatments, such as medication or laser therapy. It is also suitable for patients who are at high risk of vision loss due to uncontrolled intraocular pressure.

AADI surgery is typically performed under local anesthesia. The surgeon will make a small incision in the eye and insert the AADI. The procedure usually takes about 30 minutes. After surgery, you will be monitored for any complications and given instructions on how to care for your eye.

The success rate of AADI surgery is generally good. Studies have shown that the majority of patients who undergo AADI surgery experience a significant reduction in intraocular pressure and preservation of vision. However, it is important to note that the success of the surgery can vary depending on individual factors.